H. Remmer

7.6k total citations · 2 hit papers
154 papers, 5.9k citations indexed

About

H. Remmer is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, H. Remmer has authored 154 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pharmacology, 37 papers in Molecular Biology and 25 papers in Oncology. Recurrent topics in H. Remmer's work include Pharmacogenetics and Drug Metabolism (41 papers), Drug Transport and Resistance Mechanisms (21 papers) and Metabolism and Genetic Disorders (19 papers). H. Remmer is often cited by papers focused on Pharmacogenetics and Drug Metabolism (41 papers), Drug Transport and Resistance Mechanisms (21 papers) and Metabolism and Genetic Disorders (19 papers). H. Remmer collaborates with scholars based in Germany, United States and Italy. H. Remmer's co-authors include John B. Schenkman, Ronald W. Estabrook, H.-J. Merker, H. Kappus, R.W. Estabrook, H. J. Merker, Hermann M. Bolt, R. Fleischmann, H.-F. v. Oldershausen and B. Schoene and has published in prestigious journals such as Science, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

H. Remmer

150 papers receiving 5.3k citations

Hit Papers

Spectral Studies of Drug Interaction with Hepatic Microso... 1963 2026 1984 2005 1967 1963 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Remmer Germany 35 3.3k 1.8k 1.3k 750 641 154 5.9k
James R. Fouts United States 46 3.2k 1.0× 2.1k 1.2× 1.2k 0.9× 914 1.2× 601 0.9× 175 7.0k
R.W. Estabrook United States 37 2.8k 0.8× 2.8k 1.6× 903 0.7× 993 1.3× 370 0.6× 76 6.1k
Richard O. Recknagel United States 38 3.0k 0.9× 1.6k 0.9× 758 0.6× 565 0.8× 415 0.6× 72 6.5k
Gilbert J. Mannering United States 35 2.3k 0.7× 1.2k 0.7× 839 0.6× 605 0.8× 282 0.4× 126 3.9k
Henry W. Strobel United States 42 3.4k 1.0× 2.3k 1.3× 1.5k 1.2× 1.0k 1.3× 338 0.5× 159 6.0k
Anthony Y.H. Lu United States 48 5.4k 1.6× 3.0k 1.7× 2.4k 1.8× 1.2k 1.6× 457 0.7× 122 8.8k
Jerry R. Mitchell United States 35 2.7k 0.8× 938 0.5× 1.0k 0.8× 650 0.9× 179 0.3× 65 5.1k
Theodore E. Gram United States 35 1.5k 0.5× 1.3k 0.7× 883 0.7× 463 0.6× 320 0.5× 90 3.7k
Ingemar Björkhem Sweden 49 1.6k 0.5× 2.9k 1.6× 2.4k 1.8× 699 0.9× 1.0k 1.6× 239 7.9k
James P. Hardwick United States 39 2.6k 0.8× 2.0k 1.1× 1.3k 1.0× 806 1.1× 338 0.5× 78 5.3k

Countries citing papers authored by H. Remmer

Since Specialization
Citations

This map shows the geographic impact of H. Remmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Remmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Remmer more than expected).

Fields of papers citing papers by H. Remmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Remmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Remmer. The network helps show where H. Remmer may publish in the future.

Co-authorship network of co-authors of H. Remmer

This figure shows the co-authorship network connecting the top 25 collaborators of H. Remmer. A scholar is included among the top collaborators of H. Remmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Remmer. H. Remmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kessler, Winfried & H. Remmer. (1990). Generation of volatile hydrocarbons from amino acids and proteins by an iron/ascorbate/GSH system. Biochemical Pharmacology. 39(8). 1347–1351. 29 indexed citations
2.
Remmer, H.. (1987). Passively inhaled tobacco smoke: a challenge to toxicology and preventive medicine. Archives of Toxicology. 61(2). 89–104. 40 indexed citations
3.
Einsele, Hermann, Michael Clemens, & H. Remmer. (1985). Effect of Ascorbate on Red Blood Cell Lipid Peroxidation. Free Radical Research Communications. 1(1). 63–67. 23 indexed citations
4.
Frank, Hartmut, et al.. (1985). Formation and metabolism of nitrosaminesin vivo, monitored by15N-stable isotope labelling. Xenobiotica. 15(1). 77–86. 2 indexed citations
5.
Clemens, Michael & H. Remmer. (1982). Volatile alkanes produced by erythrocytes: An assay for in vitro studies on lipid peroxidation. Annals of Hematology. 45(5). 329–335. 22 indexed citations
6.
Remmer, H.. (1978). Primary liver tumors : proceedings of the 25th Falk Symposium, on the occasion of the 5th Centennial Celebrations of the Eberhard-Karls-Universitat Tübingen held at the Schwartzwaldhotel, Titisee, West Germany, October 3-5, 1977 .... Medical Entomology and Zoology. 1 indexed citations
7.
Wollenberg, Peter, et al.. (1976). [Effect of 2-hydroxyestradiol-17beta on NADPH-dependent electron transfer in rat liver microsomes in vitro (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 357(3). 351–7. 4 indexed citations
8.
Remmer, H., et al.. (1975). Relationship Between Microsomal Hydroxylase and Glucuronyltransferase. Advances in experimental medicine and biology. 58(0). 335–341. 3 indexed citations
9.
Remmer, H., B. Schoene, & R. Fleischmann. (1973). INDUCTION OF THE UNSPECIFIC MICROSOMAL HYDROXYLASE IN THE HUMAN LIVER. Drug Metabolism and Disposition. 1(1). 224–230. 12 indexed citations
10.
Oldershausen, H.-F. v., et al.. (1970). Der Abbau von Pentobarbital bei Lebersch�den. Journal of Molecular Medicine. 48(9). 565–567. 18 indexed citations
11.
Hildebrandt, Alfred G., H. Remmer, & R.W. Estabrook. (1968). Cytochrome P-450 of liver microsomes—One pigment or many. Biochemical and Biophysical Research Communications. 30(6). 607–612. 190 indexed citations
12.
Remmer, H., John B. Schenkman, R.W. Estabrook, et al.. (1966). Drug Interaction with Hepatic Microsomal Cytochrome. Molecular Pharmacology. 2(2). 187–190. 285 indexed citations
13.
Remmer, H. & H.-J. Merker. (1965). EFFECT OF DRUGS ON THE FORMATION OF SMOOTH ENDOPLASMIC RETICULUM AND DRUG‐METABOLIZING ENZYMES. Annals of the New York Academy of Sciences. 123(1). 79–97. 307 indexed citations
14.
Remmer, H. & Martín J. Siegert. (1960). Beschleunigung des Abbaus und Adaptation des ZNS während der Gewöhnung an Barbiturate. Naunyn-Schmiedeberg s Archives of Pharmacology. 240(1). 22–23. 5 indexed citations
15.
Remmer, H.. (1959). Der beschleunigte Abbau von Pharmaka in den Lebermikrosomen unter dem Einflu� von Luminal. Naunyn-Schmiedeberg s Archives of Pharmacology. 235(4). 279–90. 120 indexed citations
16.
Remmer, H.. (1958). [The reaction between globin and ferricyanide].. PubMed. 330(3). 232–9. 1 indexed citations
17.
Remmer, H.. (1958). Geschlechtsspezifische Unterschiede in der Entgiftung von Evipan und Thiopental bei Ratten. Naunyn-Schmiedeberg s Archives of Pharmacology. 233(2). 173–83. 36 indexed citations
18.
Remmer, H.. (1958). Die Wirkung der Nebennierenrinde auf den Abbau von Pharmaka in den Lebermikrosomen. Die Naturwissenschaften. 45(21). 522–523. 24 indexed citations
19.
Remmer, H.. (1958). Die Verst�rkung der Abbaugeschwindigkeit von Evipan durch Glykocorticoide. Naunyn-Schmiedeberg s Archives of Pharmacology. 233(2). 29 indexed citations
20.
Remmer, H.. (1956). Die Standardisierung des roten Blutfarbstoffes durch H�miglobincyanid. Naunyn-Schmiedeberg s Archives of Pharmacology. 229(5). 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026